drug
mycophenolate sodium DR
Marketedupdated 3mo agoby Wanbang Biopharmaceuticals Co Ltd
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4all catalysts(3)
Trials studying mycophenolate sodium DR
- phase3A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
- phase2Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
- phase3A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications
- phase3Myfortic vs. Cellcept in Kidney Transplant Recipients
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 18m ago
Found something off?
comments(0)
5-min edit window · permanent after that